{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:07:56Z","timestamp":1790870876573,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14239-0","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:20:11Z","timestamp":1747639211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrating single-cell and bulk RNA profiles to uncover glutamine metabolism\u2019s role in prognosis and immune dynamics in multiple myeloma"],"prefix":"10.1186","volume":"25","author":[{"given":"Fei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"10","key":"14239_CR1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/s41375-019-0561-2","volume":"33","author":"AH Bazarbachi","year":"2019","unstructured":"Bazarbachi AH, Al Hamed R, Malard F, Harousseau JL, Mohty M. Relapsed refractory multiple myeloma: a comprehensive overview. Leukemia. 2019;33(10):2343\u201357.","journal-title":"Leukemia"},{"issue":"7","key":"14239_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1182\/blood-2018-09-825331","volume":"133","author":"C Pawlyn","year":"2019","unstructured":"Pawlyn C, Davies FE. Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood. 2019;133(7):660\u201375.","journal-title":"Blood"},{"issue":"29","key":"14239_CR3","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux O, Lode L, Magrangeas F, Charbonnel C, Gouraud W, Jezequel P, Attal M, Harousseau JL, Moreau P, Bataille R, et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the intergroupe Francophone du myelome. J Clin Oncol. 2008;26(29):4798\u2013805.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14239_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-021-01162-7","volume":"14","author":"CT Wallington-Beddoe","year":"2021","unstructured":"Wallington-Beddoe CT, Mynott RL. Prognostic and predictive biomarker developments in multiple myeloma. J Hematol Oncol. 2021;14(1):151.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"14239_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40164-022-00303-z","volume":"11","author":"I Oudaert","year":"2022","unstructured":"Oudaert I, Van der Vreken A, Maes A, De Bruyne E, De Veirman K, Vanderkerken K, Menu E. Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma. Exp Hematol Oncol. 2022;11(1):49.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"14239_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12935-022-02524-y","volume":"22","author":"R Tu","year":"2022","unstructured":"Tu R, Ma J, Zhang P, Kang Y, Xiong X, Zhu J, Li M, Zhang C. The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism. Cancer Cell Int. 2022;22(1):130.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"14239_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/bjc.2014.425","volume":"111","author":"M Chiu","year":"2014","unstructured":"Chiu M, Tardito S, Pillozzi S, Arcangeli A, Armento A, Uggeri J, Missale G, Bianchi MG, Barilli A, Dall\u2019Asta V, et al. Glutamine depletion by Crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. Br J Cancer. 2014;111(6):1159\u201367.","journal-title":"Br J Cancer"},{"issue":"3","key":"14239_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1078-0432.CCR-12-2334","volume":"19","author":"M Hassanein","year":"2013","unstructured":"Hassanein M, Hoeksema MD, Shiota M, Qian J, Harris BK, Chen H, Clark JE, Alborn WE, Eisenberg R, Massion PP. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res. 2013;19(3):560\u201370.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"14239_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-01-690743","volume":"128","author":"M Bolzoni","year":"2016","unstructured":"Bolzoni M, Chiu M, Accardi F, Vescovini R, Airoldi I, Storti P, Todoerti K, Agnelli L, Missale G, Andreoli R, et al. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target. Blood. 2016;128(5):667\u201379.","journal-title":"Blood"},{"issue":"17","key":"14239_CR10","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1158\/1078-0432.CCR-12-2917","volume":"19","author":"L Puchades-Carrasco","year":"2013","unstructured":"Puchades-Carrasco L, Lecumberri R, Martinez-Lopez J, Lahuerta JJ, Mateos MV, Prosper F, San-Miguel JF, Pineda-Lucena A. Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission. Clin Cancer Res. 2013;19(17):4770\u20139.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"14239_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.metabol.2012.07.007","volume":"61","author":"MM Adeva","year":"2012","unstructured":"Adeva MM, Souto G, Blanco N, Donapetry C. Ammonium metabolism in humans. Metabolism. 2012;61(11):1495\u2013511.","journal-title":"Metabolism"},{"issue":"8","key":"14239_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427\u201333.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"14239_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/tcr-21-1554","volume":"11","author":"Z Gong","year":"2022","unstructured":"Gong Z, Li Q, Li J, Xie J, Wang W. A novel signature based on autophagy-related LncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma. Transl Cancer Res. 2022;11(1):14\u201328.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"14239_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/19336950.2021.1953322","volume":"15","author":"J Xie","year":"2021","unstructured":"Xie J, Zhu Z, Cao Y, Ruan S, Wang M, Shi J. Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma. Channels (Austin). 2021;15(1):483\u201395.","journal-title":"Channels (Austin)"},{"key":"14239_CR15","doi-asserted-by":"crossref","unstructured":"Zhao J, Wang X, Zhu H, Wei S, Zhang H, Ma L, He P. Integrative analysis of bulk RNA-Seq and Single-Cell RNA-Seq unveils novel prognostic biomarkers in multiple myeloma. Biomolecules 2022, 12(12).","DOI":"10.3390\/biom12121855"},{"key":"14239_CR16","doi-asserted-by":"publisher","first-page":"1307588","DOI":"10.3389\/fimmu.2023.1307588","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Yang L, Zhang Y, Hou Q, Wang S, Lu S, Tao Y, Hu W, Zhao L. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer. Front Immunol. 2023;14:1307588.","journal-title":"Front Immunol"},{"issue":"2","key":"14239_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"11","key":"14239_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, Rambow F, Marine JC, Geurts P, Aerts J, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"key":"14239_CR19","doi-asserted-by":"publisher","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","volume":"4","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17.","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"3","key":"14239_CR20","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"5","key":"14239_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"14239_CR22","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 2021, 22(6).","DOI":"10.1093\/bib\/bbab260"},{"issue":"8","key":"14239_CR23","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.bbmt.2019.04.005","volume":"25","author":"A D\u2019Souza","year":"2019","unstructured":"D\u2019Souza A, Hari P, Pasquini M, Braun T, Johnson B, Lundy S, Couriel D, Hamadani M, Magenau J, Dhakal B, et al. A phase 2 study of pembrolizumab during lymphodepletion after autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transpl. 2019;25(8):1492\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"key":"14239_CR24","doi-asserted-by":"publisher","first-page":"104068","DOI":"10.1016\/j.cellimm.2020.104068","volume":"351","author":"JB Allocco","year":"2020","unstructured":"Allocco JB, Alegre ML. Exploiting immunometabolism and T cell function for solid organ transplantation. Cell Immunol. 2020;351:104068.","journal-title":"Cell Immunol"},{"issue":"5","key":"14239_CR25","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","volume":"21","author":"S Dalva-Aydemir","year":"2015","unstructured":"Dalva-Aydemir S, Bajpai R, Martinez M, Adekola KU, Kandela I, Wei C, Singhal S, Koblinski JE, Raje NS, Rosen ST, et al. Targeting the metabolic plasticity of multiple myeloma with FDA-approved Ritonavir and Metformin. Clin Cancer Res. 2015;21(5):1161\u201371.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"14239_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1242\/jcs.21.3.609","volume":"21","author":"RS Roberts","year":"1976","unstructured":"Roberts RS, Hsu HW, Lin KD, Yang TJ. Amino acid metabolism of myeloma cells in culture. J Cell Sci. 1976;21(3):609\u201315.","journal-title":"J Cell Sci"},{"issue":"30","key":"14239_CR27","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/onc.2015.464","volume":"35","author":"R Bajpai","year":"2016","unstructured":"Bajpai R, Matulis SM, Wei C, Nooka AK, Von Hollen HE, Lonial S, Boise LH, Shanmugam M. Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax. Oncogene. 2016;35(30):3955\u201364.","journal-title":"Oncogene"},{"issue":"1","key":"14239_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92.","journal-title":"Signal Transduct Target Ther"},{"key":"14239_CR29","doi-asserted-by":"crossref","unstructured":"Williams AB, Schumacher B. p53 in the DNA-Damage-Repair process. Cold Spring Harb Perspect Med 2016, 6(5).","DOI":"10.1101\/cshperspect.a026070"},{"issue":"20","key":"14239_CR30","doi-asserted-by":"publisher","first-page":"12985","DOI":"10.1073\/pnas.202485699","volume":"99","author":"S Adimoolam","year":"2002","unstructured":"Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci U S A. 2002;99(20):12985\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"14239_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mrfmmm.2009.08.004","volume":"685","author":"K Sugasawa","year":"2010","unstructured":"Sugasawa K. Regulation of damage recognition in mammalian global genomic nucleotide excision repair. Mutat Res. 2010;685(1\u20132):29\u201337.","journal-title":"Mutat Res"},{"issue":"5","key":"14239_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29(5):946\u201360.","journal-title":"Cell Death Differ"},{"issue":"3","key":"14239_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.molcel.2008.04.002","volume":"30","author":"S Basak","year":"2008","unstructured":"Basak S, Jacobs SB, Krieg AJ, Pathak N, Zeng Q, Kaldis P, Giaccia AJ, Attardi LD. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol Cell. 2008;30(3):303\u201314.","journal-title":"Mol Cell"},{"issue":"16","key":"14239_CR34","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1073\/pnas.1001006107","volume":"107","author":"W Hu","year":"2010","unstructured":"Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A. 2010;107(16):7455\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"14239_CR35","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-15-3502","volume":"76","author":"E Timosenko","year":"2016","unstructured":"Timosenko E, Ghadbane H, Silk JD, Shepherd D, Gileadi U, Howson LJ, Laynes R, Zhao Q, Strausberg RL, Olsen LR, et al. Nutritional stress induced by Tryptophan-Degrading enzymes results in ATF4-Dependent reprogramming of the amino acid transporter profile in tumor cells. Cancer Res. 2016;76(21):6193\u2013204.","journal-title":"Cancer Res"},{"key":"14239_CR36","doi-asserted-by":"crossref","unstructured":"Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, Cho SH, Paik Y, Wang Q, Zhang S et al. Selective glutamine metabolism Inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest 2021, 131(4).","DOI":"10.1172\/JCI140100"},{"issue":"3","key":"14239_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. Glutamine metabolism in cancer: Understanding the heterogeneity. Trends Cancer. 2017;3(3):169\u201380.","journal-title":"Trends Cancer"},{"issue":"13","key":"14239_CR38","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.7150\/thno.73896","volume":"12","author":"S Cao","year":"2022","unstructured":"Cao S, Hung YW, Wang YC, Chung Y, Qi Y, Ouyang C, Zhong X, Hu W, Coblentz A, Maghami E, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 2022;12(13):6038\u201356.","journal-title":"Theranostics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14239-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:20:14Z","timestamp":1747639214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14239-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14239"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14239-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Sichuan Provincial People\u2019s Hospital and Sichuan Academy of Medical Sciences (2023-577). All patients gave Written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"887"}}